At present there are no treatments to stop or delay underlying disease progression. Current prevalent therapies help to mask the symptoms, but they do not solve underlying causes. A fundamental premise for effective treatment is to make a diagnosis of Alzheimer disease at the earliest stage.
At present there are no treatments to stop and/or delay underlying disease progression. Current prevalent therapies help to mask the symptoms, but they do not solve the underlying root cause(s). A fundamental premise for effective treatment is to make a diagnosis of Alzheimer disease at the earliest stage.
1. Non-employed women have more rapid memory decline compared with women who continue to engage in their careers
2. Women appear to have a comparative verbal advantage that may enable them to compensate more effectively in the early stages of Alzheimer disease.
3. Women with mild cognitive impairment had a denser distribution and higher burden of tau, which suggest that female brains may have a stronger connection with abnormal tau protein.
4. Using genome sequencing, 11 genes have been found that are related to gender: immune gene (CD1E) in women and the mucolipin gene (MCOLN3) in men appear to be risk factors for AD.
